Ms. Special Alert

Dear John,

By 5 p.m. ET on Thursday, May 14, the Supreme Court is expected to decide whether to continue preserving telehealth and mail access to mifepristone, or allow a sweeping lower-court restriction to take effect.

As we remain on Supreme Court watch, here are two important perspectives to consider: Attorney Julie Kay and Ms . contributing editor Carrie Baker explore what today’s legal fight could mean for patients, providers and the future of abortion access nationwide; and legal analyst Joyce Vance’s latest breakdown of the Louisiana v. FDA case and what to watch for next.

Telemedicine Abortion Is Not Going Away: Julie Kay Reads the Tea Leaves on Mifepristone, Shield Laws and the Supreme Court’s Latest Deadline ([link removed])

Medication Abortion Is Back Before the Supreme Court, and the Stakes Are National ([link removed])

__________

Keep Ms. strong and fiercely independent! [link removed]

[link removed] | [link removed] | [link removed]

Enjoy this newsletter? Forward to a friend!
Was this email forwarded to you by a friend? Subscribe: [link removed]


Ms. Magazine
1600 Wilson Boulevard
Suite 801
Arlington, VA 22209
United States

Manage your email subscriptions here: [link removed]
If you believe you received this message in error or wish to no longer receive email from us, please
unsubscribe: [link removed] .